Marpai, Inc. (MRAI)
OTCMKTS · Delayed Price · Currency is USD
2.230
+0.020 (0.90%)
At close: Jul 31, 2026
Marpai Market Cap
Marpai has a market cap or net worth of $56.49 million as of July 31, 2026. Its market cap has increased by 157.64% in one year.
Market Cap
56.49M
Enterprise Value
85.24M
Revenue
17.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.23
ChartMarket Cap Chart
Since October 27, 2021, Marpai's market cap has decreased from 87.06M to 56.49M, a decrease of -35.11%. That is a compound annual growth rate of -8.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 56.49M | 274.19% |
| Dec 31, 2025 | 15.10M | 10.65% |
| Dec 31, 2024 | 13.64M | -3.76% |
| Dec 29, 2023 | 14.18M | -5.96% |
| Dec 30, 2022 | 15.08M | -82.90% |
| Dec 31, 2021 | 88.14M | 1.24% |
| Oct 27, 2021 | 87.06M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 808.75M |
| Silence Therapeutics | 548.86M |
| Veradigm | 544.95M |
| Elite Pharmaceuticals | 408.11M |
| Cell Source | 60.47M |
| Sofgen Pharma | 58.35M |
| BioStem Technologies | 56.90M |
| Veri Medtech Holdings | 55.73M |